IP Library Granted Patent US 11,253,632
Granted Patent B2
US 11,253,632 · App. 16/436,578 · Granted Feb 22, 2022

Biomaterial for suturing

Inventors: Damian Garcia-Olmo (Madrid, ES); Gema Fernandez Miguel (Madrid, ES); Manuel A. Gonzalez De La Pena (Madrid, ES); Mariano G. Arranz (Madrid, ES)
Assignees: TIGENIX, S.A.U.; Universidad Autonoma de Madrid
A61L27/3804A61L17/145A61L27/3839A61L17/00C12N5/0667
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,253,632
App. No.
16/436,578
Granted
Feb 22, 2022
Kind
B2
Abstract

A biomaterial for suturing comprising a physiologically compatible support material coated with a cellular population with proliferative and/or differentiation capacity, characteristics which facilitate the regeneration of the sutured tissue. This biomaterial for suturing not only brings together the two edges of an open wound, but also contributes actively to the healing process, thereby accelerating the tissue repair process. Also disclosed are methods for making the biomaterial and methods for using the biomaterials in therapy.

Claims (9)

1. A method of suturing gastrointestinal tissue, comprising the steps of:

(a) isolating stem cells from adipose tissue of a subject, thereby obtaining adipose derived stem cells;

(b) adhering the adipose derived stem cells to a thread such that the adipose derived stem cells coat the thread; and

(c) bringing edges of tissue together using the thread by introducing the thread in the tissues using a metal needle and passing the needle successively between the edges of the tissue.

2. The method of claim 1 , wherein the adipose derived stem cells are allogeneic adipose derived stem cells.

3. The method of claim 1 , wherein the adipose derived stem cells are obtained by liposuction.

4. The method of claim 1 , wherein the thread is a monofilament or multifilament thread.

5. The method of claim 1 , wherein the thread is absorbable.

6. The method of claim 1 , wherein the thread is made of a natural material.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: TIGENIX, S.A.U.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 060516/0532 →
CHANGE OF NAME Recorded Aug 31, 2021
From: TIGENIX, S.A.
To: TIGENIX, S.A.U.
Reel/Frame 058280/0705 →
CHANGE OF NAME Recorded Aug 30, 2021
From: CELLERIX, S.A.U.
To: TIGENIX, S.A.U.
Reel/Frame 057351/0351 →
CHANGE OF NAME Recorded May 1, 2020
From: CELLERIX, S.A.
To: TIGENIX, S.A.
Reel/Frame 052550/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2020
From: ARRANZ, MARIANO G.
To: UNIVERSIDAD AUTONOMA DE MADRID
Reel/Frame 051642/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2020
From: GARCIA-OLMO, DAMIAN
To: UNIVERSIDAD AUTONOMA DE MADRID
Reel/Frame 051722/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2020
From: MIGUEL, GEMA FERNANDEZ; GONZALEZ DE LA PENA, MANUEL A.
To: CELLERIX, S.L.
Reel/Frame 051723/0982 →
Priority Claims (1)
ES 200402083 · Aug 25, 2004 · national
Continuity (3)
Continuation 12533875 · Jul 31, 2009
Continuation 11056241 · Feb 14, 2005
Related Publication 20200101199A1 · Apr 2, 2020